GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » E10

Hansa Biopharma AB (OSTO:HNSA) E10 : kr-9.62 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hansa Biopharma AB's adjusted earnings per share data for the three months ended in Mar. 2024 was kr-4.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-9.62 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -23.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hansa Biopharma AB was -23.60% per year. The lowest was -23.60% per year. And the median was -23.60% per year.

As of today (2024-06-05), Hansa Biopharma AB's current stock price is kr49.66. Hansa Biopharma AB's E10 for the quarter that ended in Mar. 2024 was kr-9.62. Hansa Biopharma AB's Shiller PE Ratio of today is .


Hansa Biopharma AB E10 Historical Data

The historical data trend for Hansa Biopharma AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB E10 Chart

Hansa Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -4.88 -5.87 -7.46 -9.22

Hansa Biopharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.84 -8.43 -8.91 -9.22 -9.62

Competitive Comparison of Hansa Biopharma AB's E10

For the Biotechnology subindustry, Hansa Biopharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansa Biopharma AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's Shiller PE Ratio falls into.



Hansa Biopharma AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hansa Biopharma AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-4.15/132.2054*132.2054
=-4.150

Current CPI (Mar. 2024) = 132.2054.

Hansa Biopharma AB Quarterly Data

per share eps CPI Adj_EPS
201406 -0.180 100.432 -0.237
201409 -0.200 100.161 -0.264
201412 -0.470 100.225 -0.620
201503 -0.390 99.950 -0.516
201506 -0.700 99.995 -0.925
201509 -0.430 100.228 -0.567
201512 -0.580 100.276 -0.765
201603 -0.610 100.751 -0.800
201606 -0.940 101.019 -1.230
201609 -0.830 101.138 -1.085
201612 -0.980 102.022 -1.270
201703 -1.270 102.022 -1.646
201706 -1.280 102.752 -1.647
201709 -1.060 103.279 -1.357
201712 -1.340 103.793 -1.707
201803 -1.230 103.962 -1.564
201806 -1.550 104.875 -1.954
201809 -1.610 105.679 -2.014
201812 -2.090 105.912 -2.609
201903 -1.810 105.886 -2.260
201906 -2.060 106.742 -2.551
201909 -2.360 107.214 -2.910
201912 -2.770 107.766 -3.398
202003 -2.330 106.563 -2.891
202006 -2.480 107.498 -3.050
202009 -2.770 107.635 -3.402
202012 -2.370 108.296 -2.893
202103 -2.340 108.360 -2.855
202106 -2.980 108.928 -3.617
202109 -3.340 110.338 -4.002
202112 -3.680 112.486 -4.325
202203 -3.110 114.825 -3.581
202206 -3.820 118.384 -4.266
202209 -3.450 122.296 -3.730
202212 -3.210 126.365 -3.358
202303 -3.920 127.042 -4.079
202306 -4.790 129.407 -4.894
202309 -4.780 130.224 -4.853
202312 -2.340 131.912 -2.345
202403 -4.150 132.205 -4.150

Add all the adjusted EPS together and divide 10 will get our e10.


Hansa Biopharma AB  (OSTO:HNSA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hansa Biopharma AB E10 Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansa Biopharma AB (OSTO:HNSA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines